Treatment - SAVIMS

References: Powerpoint Presentation of Practical Guidelines for the therapeutic use of Ivermectin citing various publications. Compiled 2023, Dr Stephen J Schmidt. Summary: A powerpoint presentation highlighting the history of Avermectins and consequent development of the therapeutic drug commonly known as Ivermectin. The uses for various medical conditions are listed, as well as suggested protocol for

Bioresonance therapy, COVID-19, Covid-19 vaccines, Photobiomodulation, Reference Library, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 29/06/2023 | Bioresonance therapy, COVID-19, Covid-19 vaccines, Photobiomodulation, Reference Library, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Covid-19 vaccines, Ivermectin, Reference Library, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

Restricted content

Suzanne | 20/04/2023 | COVID-19, Covid-19 vaccines, Ivermectin, Reference Library, Treatment, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of Early COVID-19 Treatment Protocols

Director | 30/03/2023 | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE early COVID treatment summary. Retrieved from https://www.flccc.net Summary: The FLCCC Alliance outlines a structured protocol for the early treatment of COVID-19, emphasising the importance of immediate intervention after the onset of symptoms. First-line treatments include Ivermectin (0.4-0.6 mg/kg), Hydroxychloroquine (200 mg twice daily), and antiseptic mouthwash for symptom management. Ivermectin

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

I-CARE Early COVID Treatment Protocol Overview

Director | 30/03/2023 | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-CARE: Early COVID treatment protocol. Retrieved from [insert link] Summary: The I-CARE protocol, developed by the FLCCC Alliance, aims to provide healthcare professionals with a structured approach to early COVID-19 treatment, focusing on preventing hospitalisation and mortality. The protocol recommends a combination of first-line treatments such as ivermectin, hydroxychloroquine, and various

General Health, Reference Library, Treatment

Restricted content

Suzanne | 17/03/2023 | General Health, Reference Library, Treatment

COVID-19, General Health, Ivermectin, Nutrition - supplements, Other repurposed substances, Reference Library, Treatment, Viral illnesses

Restricted content

Suzanne | 16/03/2023 | COVID-19, General Health, Ivermectin, Nutrition - supplements, Other repurposed substances, Reference Library, Treatment, Viral illnesses

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Prevention Strategies Against COVID-19, Influenza, and RSV – SUMMARY

Director | 02/02/2023 | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2023). I-PREVENT COVID, FLU AND RSV protection. Retrieved from www.flccc.net Summary: The I-PREVENT protocol is designed for healthcare workers, high-risk individuals, and those with co-morbidities to mitigate the risks of COVID-19, influenza, and RSV infections. Recommended interventions include antiseptic mouthwashes containing chlorhexidine, povidone-iodine, or cetylpyridinium chloride, and supplementation with Vitamin D, Vitamin